In pancreatic cancer, overexpressed EGFR regulates downstream signaling activation, including PKC, PI3K/AKT/mTOR, SRC, STAT and RAS/RAF/MEK1/ERK1/2, and regulate numerous EGFR-interacting proteins [30,31]. The gene discussed is MAPK3; the disease is familial pancreatic carcinoma.